2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Wednesday, June 7, 2017

1:15pm-2:45pm: Predictive Ability of Clinical Timed Tests for Postural Instability and Gait Difficulty in Parkinson’s Disease

M. Bryant, J.-G. Hou, F. Jamal, G. Jackson, C. Workman, E. Protas (Houston, TX, USA)

Phenomenology and Clinical Assessment Of Movement Disorders · Exhibit Hall C

1:15pm-2:45pm: Predictor of progressive mild cognitive impairment in patients with Parkinson’s disease.

Y. Tajiri, K. Wada-Isoe, M. Hamada, M. Sawada, K. Nakashima (Yonago, Japan)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Predictors of onset of psychosis in Parkinson’s disease: “Who gets it early?”

P. Pal, A. Lenka, L. George, S. Arumugham, S. Hegde, N. Kamble, R. Yadav (Bangalore, India)

Parkinson's Disease: Psychiatric Manifestations · Exhibit Hall C

1:15pm-2:45pm: Preliminary results of 18F-DTBZ PET study in the patients with vascular parkinsonism

W.-Y. Lin, Y.-H. Weng, K.-J. Lin, C.-S. Lu (Taoyuan, Taiwan)

Neuroimaging (Non-PD) · Exhibit Hall C

1:15pm-2:45pm: Presence of abnormalities on structural MRI associate with faster disease progression in multiple system atrophy

K. Seppi, F. Krismer, G. Wenning, S. Papapetropoulos, V. Abler, W. Poewe (Innsbruck, Austria)

Neuroimaging (Non-PD) · Exhibit Hall C

1:15pm-2:45pm: Pro-saccades predict decline in attention over 18months in newly diagnosed Parkinson’s disease

S. Stuart, L. Alcock, J. Nell, R. Lawson, R. Morris, A. Yarnall, D. Burn, L. Rochester (Newcastle Upon Tyne, United Kingdom)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Progression to Parkinson’s disease in carriers of LRRK2 G2019S mutation: a 4-year prospective study with serial dopamine transporter imaging

J. Infante, M. Sierra, I. Martínez-Rodríguez, P. Sánchjez-Juan, I. González-Aramburu, M. Jimenez-Alonso, A. Sánchez-Rodriguez, I. Banzo (Santander, Spain)

Parkinson's Disease: Genetics · Exhibit Hall C

1:15pm-2:45pm: Progressive ataxia and palatal tremor: 2 autopsy cases of a novel tauopathy

A. Gao, A. Faust-Socher, M. Del Bigio, A. Lang, D. Munoz (Toronto, ON, Canada)

Ataxia · Exhibit Hall C

1:15pm-2:45pm: Prospective longitudinal CSF measurements and cognitive decline in GBA-associated Parkinsonism: not Abeta or Tau but Lewy body pathology?

S. Lerche, C. Schulte, K. Srulijes, A. Pilotto, T. Rattay, A.-K. Hauser, E. Stransky, C. Deuschle, I. Csoti, H. Zetterberg, I. Liepelt-Scarfone, T. Gasser, W. Maetzler, D. Berg, K. Brockmann (Tübingen, Germany)

Parkinson's Disease: Cognition · Exhibit Hall C

1:15pm-2:45pm: Protective effect of Myristicin against neurodegeneration in a 6-hydroxydopamine induced model of Parkinson’s disease in rats

A. Morad Ganjeh (Karaj, Islamic Republic of Iran)

Neuropharmacology · Exhibit Hall C